Seung-Jung Park

Apr 15, 2024 | healio.com | Erik Swain |Richard Smith |Seung-Jung Park

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: For patients with vulnerable plaque but no flow-limiting stenosis, PCI provided better clinical outcomes than medical therapy at 2 years. The results held at 7 years and may suggest a new population for PCI.

Apr 8, 2024 | thelancet.com | Seung-Jung Park |Jung-Min Ahn |Do-Yoon Kang

Summary Acute coronary syndrome and sudden cardiac death are often caused by rupture and thrombosis of lipid-rich atherosclerotic coronary plaques (known as vulnerable plaques), many of which are non-flow-limiting. The safety and effectiveness of focal preventive therapy with percutaneous coronary intervention of vulnerable plaques in reducing adverse cardiac events are unknown.